Navigating health care insurance coverage can be a supremely convoluted process for anyone, especially patients or caregivers recently faced with coping with a life-threatening disease. While the advancement of many new treatments and scientific innovations in…
The evolving landscape of HCP and patient engagement in the pharmaceutical industry necessitates omnichannel solutions that successfully cover multiple touchpoints such as field, web, email, conferences and more. Not only are brands expected to cover these…
The traditional mindset toward established brands in the pharmaceutical industry has largely been to let focus fade from them and shift entirely to developing and launching new products. With emphasis placed almost exclusively on new product…
Maximizing revenue potential throughout products’ entire lifecycles before they reach loss of exclusivity (LOE) is the most impactful return on investment manufacturers can make for their established brands. While many companies figuratively put their mature brands…
In the pharmaceutical industry, bringing a new drug to market is a multifaceted and challenging endeavor, and ensuring commercial readiness requires a holistic and intricate approach to strategy development and enactment. EVERSANA COMPLETE Commercialization® is a…
The life sciences sector is changing for the new pharma generation with the introduction of many forms of updated technology and solutions. Continuous manufacturing (CM) is a perfect example. CM is a method for manufacturing pharmaceutical…
Discover the groundbreaking strategy that could redefine pharmaceutical launches and propel your product’s success across North America. In the realm of pharmaceutical launches, a paradigm shift is underway, challenging the conventional sequential approach and calling for…
Author: Kirk Szafranski, Director, HEOR, Value & Evidence Health Economics and Outcomes Research (HEOR) programs play a pivotal role in assessing a product’s value, cost-effectiveness, and real-world impact on patient outcomes, which are critical factors influencing…
The use of automation continues to be on the rise, and that trajectory is not slowing down anytime soon, if ever. In relation to pharmacovigilance, automation’s ascent and how it is impacting the industry is especially…
“The Rising Demand for Light Medical Aesthetic in China” provides a captivating insight into the surging popularity of non-surgical medical aesthetics in China. The article highlights the rapid growth of the medical aesthetic market and the…